tirzepatide fda approved FDA approves new obesity drug

Indications for Semaglutide While semaglutide was initially developed to treat type 2 diabetes (marketed as Ozempic), it has been shown to be effective for weight management in individuals without diabetes as well

Remodeling of fibrous extracellular matrices by contractile cells: predictions from discrete fiber network simulations

A Roux-en-Y gastric bypass (RYGB) , where the stomach is divided, then the small intestine is attached directly to the smaller pouch, bypassing the rest of the stomach

Sarcopenic obesity is a condition characterized by the co-existence of low muscle mass (sarcopenia) and high fat mass (obesity)

Concurrently, HIF-1 activates key glycolytic enzymes, including hexokinase 2 (HK2), which catalyzes the phosphorylation of glucose to glucose-6-phosphate, and pyruvate kinase M2 (PKM2), which governs the final step of glycolysis by converting phosphoenolpyruvate to pyruvate (68)